首页|布洛芬-香豆素杂合衍生物的合成及抗肿瘤活性研究

布洛芬-香豆素杂合衍生物的合成及抗肿瘤活性研究

扫码查看
目的:设计、合成一系列新型的布洛芬-香豆素杂合衍生物,以期获得高效低毒的新型抗肿瘤药物先导化合物。方法:根据药物拼合原理,以双酰肼(-CONHNHOC-)、噁二唑、酰腙键(-CONHN=C-)作为链接基团,以香豆素和布洛芬为药效基团合成布洛芬-香豆素衍生物。通过1H NMR、13C NMR、HRMS等方法对目标化合物的结构进行表征。运用CCK-8法检测目标化合物对人肝癌细胞(HepG2)以及宫颈癌细胞(Hela)的抗增殖活性。结果:共合成11个目标化合物,所有目标化合物的1H NMR、13C NMR、HRMS都与预期目标化合物结构相一致,超高效液相色谱(UPLC)的测定结果显示化合物纯度均大于95%。体外细胞活性结果表明化合物10c的活性最为优异,对HepG2细胞和Hela细胞的IC50分别为5。044μmol/L和3。593μmol/L,优于合成基团之一布洛芬,优于常用抗肿瘤药物吉非替尼。结论:布洛芬与天然亚活性香豆素拼合具有潜在协同抗肿瘤活性,酰腙基团的引入可能对该类化合物抗肿瘤活性具有重要影响,也为进一步的结构修饰提供思路。
Synthesis and Anti-tumor Activity of Ibuprofen-Coumarin Derivatives
Objective To design and synthesize new ibuprofen-coumarin derivatives to obtain new lead compounds for anti-tumor drugs with high efficiency and low toxicity.Methods According to the drug hybridization,ibuprofen-coumarin deriv-atives were synthesized using the dihydrazide (-CONHNHOC-),oxadiazole,and hydrazone bond (-CONHN=C-) as linking groups,and coumarin and ibuprofen as pharmacophores.The structure of the target compounds was characterized by1H NMR,13C NMR,and HRMS,and their anti-proliferative activity against human hepatoma cells ( HepG2) and cervi-cal cancer cells ( HeLa) was detected using the CCK-8 assay.Results Eleven target compounds were synthesized,and their 1H NMR,13C NMR,and HRMS were consistent with the predicted stuctures.The ultra-high performance liquid chromatogra-phy (UPLC) showed that the purity of the compounds was all greater than 95%.The in vitro cell activity analysis found that compound 10c had the optimal activity,with the IC50 of 5.044 μmol/L and 3.593 μmol/L against HepG2 cells and HeLa cells,respectively,which was better than ibuprofen and the commonly used anti-tumor drug gefitinib.Conclusion Ibuprofen combined with natural subactive coumarin has potential synergistic anti-tumor activity,and hydrazone groups have an impor-tant effect on the anti-tumor activity.The present study provides ideas for further structural modifications.

IbuprofenCoumarinCombinationAnti-tumor activity

罗懿文、汤晓雨、陈伟、罗超、马俊凯、胡扬根、王天帅

展开 >

湖北医药学院第一临床学院,湖北 十堰 442000

湖北医药学院药学院,湖北 十堰 442000

湖北医药学院全科医学院,湖北 十堰 442000

湖北医药学院基础医学院,湖北 十堰 442000

湖北医药学院武当特色中药研究湖北省重点实验室,湖北 十堰 442000

展开 >

布洛芬 香豆素 拼合 抗肿瘤

2024

湖北医药学院学报
湖北医药学院

湖北医药学院学报

影响因子:0.504
ISSN:1006-9674
年,卷(期):2024.43(6)